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DIAGNOSIS AND THERAPY IN TRANSITORY MYOCARDIAL ISCHEMIA 
IN SPONTANEOUS SUBARACHNOID HEMORRHAGE 
 
Anica Pavlovic 
 
 
Cardiac dysfunction occurring within subarachnoid hemorrhage named neurogenic 
stunned myocardium have great impact on intensive care of patients with subarachnoid 
hemorrhage (SAH). Timely diagnosis and treatment of such condition can provide 
better haemodynamics of damaged brain. The standard follow-up was performed in 30 
patients with SAH during two years at the Clinic of Neurosurgery (2005, 2006). Serial 
electrocardiography, echocardiography, as well as laboratory findings of special 
biomarkers of left ventricular wall motion abnormalities were performed. All patients 
were treated with Urapidil, Metoprolol, MgSO4 by scheme and ACE inhibitors. Ninety 
EKG were analyzed in the study, as well as 16 echocardiographies. The highest levels 
of CPK, CK-MB and TnI before and after the therapy were also recoded. EKGs showed 
the signs of ischemia in 9 of 30 patients at day 1 and 7 of 30 patients at day 3 of the 
therapy. The highest level of CK-MB was present during the 1st day with mean value of 
67,80±1,83 IU/l that decreased  at day 3 of the therapy with mean value of 66,8±1,83 
IU/l, TnI was positive in 16 cases. It showed statistically significant decrease from 0,29 
ng/ml till 0,187 ng/ml and p<0,01. Myocardial ischemia has been proven to be a very 
significant complication in SAH.  Appropriate treatment of myocardial ischemia seems 
to improve systemic haemodynamics, as well as haemodynamics of the damaged 
brain. Acta Medica Medianae 2008;47(1):19-21. 
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Introduction 
 
Spontaneous subarachnoid hemorrhage 
(SAH) originating from aneurysm is a condition 
with extremely high mortality and morbidity 
rates. The prevalence for this condition is 
1/10,000 in Europe and there are 28,000 people 
with this condition in the USA every year. Out of 
the total number of the patients with this 
condition, 10-15% die before reaching hospital 
and the mortality rate within the first month 
amounts to 35-47% (1,2). 
The disruption of the myocardial function is 
a significant complication of this condition because 
it can additionally disrupt haemodynamics of the 
damaged brain (3). Experimental studies have 
shown that excessive release of noradrenaline on 
parasympathetic nerve fibers of the myocardium 
causes cardial dysfunction (4,5). The noradrena-
line release represents a response to the 
hypothalamic dysfunction caused by blood rupture 
into the subarchnoid space (4,5,6,7).  
The aim of this study was to prove the 
existence of myocardial ischemia in SAH as well 
as to examine the effects of cardio-specific 
therapy on such disorders.   
 
Material and methods 
 
A prospective study was conducted on 
thirty patients during the period of two years 
(2005-2006). The basic criterion for including a 
patient into the study was: zero day of aneurism 
hemorrhage and negative anamnesis of coronary 
disorder. This study monitored the following 
parameters: 1) changes in EKG (rhythm, ST 
elevation, ST depression, negative T-waves, QRS 
complex width), 2) Biomarkers of myocardial 
ischemia (CPK, CK-MB and Tni test) and 3) 
Echocardiographic ischemia markers. On admission, 
patients were immediately clinically and neuro-
logically tested, CT scanned (or the patients 
admitted had already been CT scanned). After the 
admission, biomarkers of ischemia i.e. myocardium 
necrosis were determined, and continuous two-
lead EKG monitoring and continuous TA 
monitoring and pulse oximetry were performed. 
In addition to initial SAH therapy (anti-
edematose therapy, sedoanalgesia, crystalloid 
and oxygenotherapy O2=2lit/min), the patients 
were also administered specific cardiologic 
therapy. It included administering Urapidil of Diagnosis and therapy in transitory myocardial ischemia in spontaneous...                Anica Pavlovic 
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12.5 mg dosage every 15 min until the desired 
MAP is achieved, along with Metoprolol at 
maximum dosage of 15 mg IV/24 h and desired 
SF to 60/min. In addition, a maximum daily 
dosage of MgSO4 at 30 mg/kg TT/24
h was 
administered. All results were statistically analyzed 
using standard descriptive methods (mean 
value). The trends of increase and decrease of 
myocardial ischemia signs were calculated using 
Kaplan-Meier analysis. The obtained results were 
analyzed using Student’s t-test for unpaired and 
paired samples by univariate and multivariate 
regression analyses. 
 
Results 
 
The total number of examined patients was 
30, 13 of which were male (43%) and 17 were 
female (57%). 
Muškarci
Žene
 
Graph 1. The structure of examinees by gender 
 
The average age of examinees was 
58.33±9.01 years. The mean age of male patients 
was 57.77±9.48 years, whereas for female patients 
it was 58.76±8.91 years. Furthermore, there were 
no statistically significant differences among 
patients of the same gender in terms of age 
(t=0.29 and p>0.05). The structure of EKG 
changes over days is shown in a graph.  
On admission, during the first day 93.3% 
of patients had CK-MB>10 IU/lit, whereas during 
the third day the percentage increased to 96.7% 
(χ
2=0,02 and p>0,05). 
The values of the troponin test on admission 
were 0.29±0.77 ng/ml on average. On the first day, 
these values statistically significantly decreased 
to 0.24±0.63 ng/ml (p<0.01), whereas on the 
third day a significant plunge of values in compa-
rison to the original value and in comparison to 
the TnI value from the first day (p<0.05) was 
noticeable (p<0.001) (See appendix 3). 
On admission, ECHO heart test was 
performed in 8 patients and ischemia changes 
were diagnosed in 7 patients. The troponin test 
values were increased in 6 patients with ischemia 
changes (true positive values – SP), whereas in 
one patient with ischemia the troponin test value 
was lower than 0.04 ng/ml (false negative value 
– LN). Based on these data, diagnostic characte-
ristics of the troponin test were calculated:    
Test sensitivity (possibility to determine 
true positive value) was 85.7%; specificity 
(possibility to determine true negative value) was 
100.0%, whereas total efficacy of the troponin 
test was 87.5%.  
 
 
 
Graph 2. EKG changes in patients with SAH 
 
Table 1. Table of CK-MB values (IU/L) 
 
Statistical  
parameter 
On 
admission 
Day 1  Day 3 
Xsr 57,80  66,80  58,59 
SD 10,062  12,054  9,152 
Min 9,00  8,00  7,00 
 
Table 2. Troponin test values (ng/ml) 
 
Statistical  
parameter 
On 
admission 
Day 1  Day 3 
Xsr 57,80  66,80  58,59 
SD 10,062  12,054  9,152 
Min 9,00  8,00  7,00 
 
Discussion 
 
The first aim of the study was to prove the 
existence of myocardial ischemia. Diagnostics of 
this problem may be included in considering 
further therapy of patients with SAH. EKG 
changes found in patients with SAH were not 
single markers of ischemia (8,9,10,11). They are 
significant in correlation with highly specific 
biomarkers (TnI and CK-MB for myocardium 
necrosis). In Naidech and Kathavale (9,10), EKG 
changes were not considered when estimating 
the degree of dysfunction of the left ventricle in 
SAH. Increased TnI values are highly specific for 
the existence of significant myocardial lesion and 
are connected with the dysfunction of the left 
ventricle in SAH (9). This was also shown by the 
Kathavale study (9). In our study, significantly 
increased TnI values are a justification for the 
application of a cardio-specific therapy for the 
treatment of myocardial ischemia. The decrease 
in the TnI level is statistically significant and 
proves that the selection of medicines for the 
study was justified. Considering the fact that no 
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prospective randomized study was conducted with 
the patients who had not received myocardium 
support therapy, it can be assumed that cardio-
specific medicines have a positive effect on 
haemodynamics in SAH. As the sensitivity of the 
troponin test in comparison with echocardio-
graphic monitoring of the patient is highly 
specific and amounts to 85.7%, the total efficacy 
of the troponin test enables a relevant estimate 
of myocardial condition, based on TnI analyses 
when there are no conditions for echocardiographic 
monitoring.  
 
Conclusion 
 
Timely and specific therapy of this significant 
complication of spontaneous subarachnoid hemo-
rrhage may contribute to faster and easier recovery 
of systemic haemodynamics, and consequently, 
improve haemodynamics of cerebral circulation. 
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DIJAGNOZA I TERAPIJA TRANZITORNE ISHEMIJE MIOKARDA U 
SPONTANOJ SUBARAHNOIDALNOJ HEMORAGIJI 
 
Anica Pavlović 
 
 
Miokardijalna disfunkcija nastala u okviru spontane subarahnoidalne hemoragije (SAH) 
ima veliki uticaj na intenzivno lečenje ovih bolesnika. Pravovremena dijagnostika i tretman 
ove komplikacije SAH-a može omogućiti bolju hemodinamiku oštećenom mozgu. Tokom 
2005. i 2006. godine na Klinici za neurohirurgiju u Nišu praćeno je 30 bolesnika po tipu 
prospektivne studije. Praćeni su: promene u EKG-u, biomarkeri ishemije (nekroze 
miokarda) i ehokardiografske promene. Svim bolesnicima su ordinirani Urapidil, 
Metoprolol, MgSO4 po šemi kao i ACE inhibitori. Analizirano je 90 EKG-a, 16 EHO-a 
miokarda kao i najviše plazma koncentracije enzima CPK, CK-MB i TnI pre i posle 
uključivanja terapije u prva tri dana bolesti. Analizom EKG-a nađeno je da 9 od 30 
bolesnika ima znake značajne ishemije prvog dana a 7 od 30 bolesnika trećeg dana 
bolesti. Najvišu plazma koncentraciju CK-MB nalazimo u prvom danu bolesti kod bolesnika 
sa srednjom vrednošću 67,8±1,83 IU/L sa padom plazma koncentracije u trećem danu i 
srednjom vrednošću od 66,8±1,80 IU/L. TnI je bio pozitivan (>0,04 ng/ml) kod 16 
bolesnika gde TnI pokazuje statistički značajan pad vrednosti od 0,29 ng/ml prvog dana do 
0,187 ng/ml i p<0,01. TnI test u poređenju sa EHO nalazima pokazuje visoku specifičnost 
85,7% i ukupnu efikasnost od 87,5%. 
Izbor ovakve kardiospecifične terapije kroz ovu studiju pokazuje se relevantnim zbog 
negativnog trenda kretanja plazma koncentracija svih biomarkera ishemije (nekroze) 
miokarda. Acta Medica Medianae 2008;47(1):19-21. 
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